Clinical Trials
86 trialsNCT07608848 2026-05-27
DOTA-STR-17126
Integrated Haematology and Oncology Network
Phase EARLY_PHASE1 Not yet recruiting
NCT05851365 2026-05-04
Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer
University of California, San Francisco
Phase EARLY_PHASE1 Active not recruiting
NCT02526368 2026-04-30
Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer
University of California, San Francisco
Phase EARLY_PHASE1 Recruiting
NCT04305925 2026-04-24
Focal Laser Ablation of Prostate Cancer
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT05047965 2026-04-15
An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT07516704 2026-04-08
Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of High-Risk Prostate Cancer: A Multicenter Prospective, Single-Arm Clinical Study
Zhongda Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT05477823 2026-03-20
Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer
University of Wisconsin, Madison
Phase EARLY_PHASE1 Active not recruiting
NCT04857502 2026-03-13
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT01804712 2026-03-12
Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy
University of California, San Diego
Phase EARLY_PHASE1 Completed
NCT07164027 2026-03-10
Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT05045066 2026-03-02
Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
Mayo Clinic
Phase EARLY_PHASE1 Recruiting
NCT06759701 2026-02-27
Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT03334500 2026-02-20
Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate Cancer
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Active not recruiting
NCT03861676 2026-02-13
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Recruiting
NCT05683964 2026-02-13
Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression
Beth Israel Deaconess Medical Center
Phase EARLY_PHASE1 Active not recruiting
NCT05160597 2026-02-12
Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT07381582 2026-02-02
161Tb-LNC1011
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT05530655 2026-01-13
A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer
University of Rochester
Phase EARLY_PHASE1 Recruiting
NCT02415621 2025-12-04
Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Active not recruiting
NCT03511196 2025-12-04
Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Active not recruiting
NCT05515978 2025-12-04
PragMet
University of Colorado, Denver
Phase EARLY_PHASE1 Recruiting
NCT06866548 2025-12-04
Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
Shanghai Changzheng Hospital
Phase EARLY_PHASE1 Active not recruiting
NCT03734653 2025-11-06
Testosterone Therapy in Castration Resistant Prostate Cancer
University of Colorado, Denver
Phase EARLY_PHASE1 Completed
NCT03507608 2025-10-16
Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Completed
NCT04576871 2025-08-28
Re-treatment 225Ac-J591 for mCRPC
Weill Medical College of Cornell University
Phase EARLY_PHASE1 Completed
NCT05802121 2025-08-20
Akkermansia Muciniphilia and Metabolic Side Effects of ADT
Western University
Phase EARLY_PHASE1 Recruiting
NCT04301414 2025-08-07
Neo-Red-P
Columbia University
Phase EARLY_PHASE1 Completed
NCT03392181 2025-05-23
PET/MRI for the Staging of Newly Diagnosed Prostate Cancer
Northwestern University
Phase EARLY_PHASE1 Active not recruiting
NCT05852041 2025-05-22
rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance
Northwestern University
Phase EARLY_PHASE1 Recruiting
NCT03987217 2025-05-14
Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients
University of Utah
Phase EARLY_PHASE1 Completed
NCT03661437 2025-04-11
Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy
City of Hope Medical Center
Phase EARLY_PHASE1 Completed
NCT03768349 2025-04-06
PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT06864572 2025-03-07
[68Ga]Ga-P17-079 in the Diagnosis and Treatment of Metastatic Prostate Cancer
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Enrolling by invitation
NCT05110495 2025-02-17
WINGMEN
University of Oxford
Phase EARLY_PHASE1 Completed
NCT06359821 2025-02-14
Evaluate Safety, Whole-Body Distribution and Radiation Dosimetry in Metastatic Castration Resistant Prostate Cancer
Sichuan University
Phase EARLY_PHASE1 Completed
NCT03232164 2024-12-12
PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer
University of Wisconsin, Madison
Phase EARLY_PHASE1 Completed
NCT05707182 2024-09-25
18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: a Pilot Study
University of Alabama at Birmingham
Phase EARLY_PHASE1 Withdrawn
NCT06612580 2024-09-25
68Ga-AAZTA-NI-093 PET/CT: First-in-human Study
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Recruiting
NCT02952469 2024-09-03
Biodistribution/Reproducibility Ga-68 PSMA-HBED-CC
University of Iowa
Phase EARLY_PHASE1 Completed
NCT04067960 2024-08-14
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT06546527 2024-08-09
Study of [177Lu]Lu-PSMA-137 In Metastatic Castrate Resistant Prostate Cancer（mCRPC）
Peking University First Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT05549024 2024-07-05
68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Recruiting
NCT03275857 2024-06-10
Cisplatin in Castration Resistant Prostate Cancer
University of Rochester
Phase EARLY_PHASE1 Completed
NCT06437496 2024-05-31
68Ga-AAZTA-093 PET/CT: First-in-human Study
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Recruiting
NCT02113657 2024-05-24
T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT03358563 2024-05-03
Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer
University of Wisconsin, Madison
Phase EARLY_PHASE1 Completed
NCT05238831 2024-01-23
SMMART Adaptive Clinical Treatment (ACT) Trial
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Withdrawn
NCT05567679 2023-09-22
A Study of Tazemetostat (Tazverik) Before Prostatectomy in Men With Prostate Cancer
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT06050239 2023-09-22
Study of 177Lu-PSMA-0057 in Metastatic Prostate Cancer
Nanjing First Hospital, Nanjing Medical University
Phase EARLY_PHASE1 Unknown
NCT04831541 2023-09-21
68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancer
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Unknown